Illumina Financial Statements
NASDAQ: ILMNHealthcareDiagnostics & ResearchUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 267.81 +0.02%
Illumina revenue and earnings
In fiscal 2025, Illumina generated $4.34 billion in revenue, down 0.7% from fiscal 2024, its first annual decline since 2024. Net income was $850.0 million, for a net margin of 19.6% versus a median of -25.8% in the prior 5 years. Gross margin was 66.1% (up from 65.4%) and operating margin 18.6%.
Diluted earnings per share came in at $5.45. Over the last 5 fiscal years, ILMN's revenue has grown at a 6.0% compound annual rate.
Summary generated from market data by MetaCap's automated system. Methodology
Illumina income statement (annual)
| Fiscal year (USD) | FY 20252025-12-28 | FY 20242024-12-29 | FY 20232023-12-31 | FY 20222023-01-01 | FY 20212022-01-02 | FY 20202021-01-03 | FY 20192019-12-29 | FY 20182018-12-30 | FY 20172017-12-31 | FY 20162017-01-01 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 4.34B | 4.37B | 4.50B | 4.58B | 4.53B | 3.24B | 3.54B | 3.33B | 2.75B | 2.40B |
| Revenue growth (YoY) | -0.66% | -2.93% | -1.75% | +1.28% | +39.73% | -8.58% | +6.30% | +21.11% | +14.76% | +8.02% |
| Cost of Revenue | 1.47B | 1.51B | 1.76B | 1.61B | 1.37B | 1.04B | 1.08B | 1.03B | 926.00M | 732.00M |
| Gross Profit | 2.87B | 2.86B | 2.74B | 2.97B | 3.15B | 2.20B | 2.47B | 2.30B | 1.83B | 1.67B |
| Operating Expenses | 2.06B | 3.69B | 3.81B | 7.15B | 3.28B | 1.62B | 1.48B | 1.42B | 1.22B | 1.08B |
| Research & Development | 967.00M | 1.17B | 1.35B | 1.32B | 1.19B | 682.00M | 647.00M | 623.00M | 546.00M | 504.00M |
| Selling, General & Admin | 1.09B | 1.09B | 1.61B | 1.30B | 2.09B | 941.00M | 835.00M | 794.00M | 674.00M | 584.00M |
| Operating Income | 807.00M | -833.00M | -1.07B | -4.18B | -123.00M | 580.00M | 985.00M | 883.00M | 606.00M | 587.00M |
| Interest Expense | 101.00M | 100.00M | 77.00M | 26.00M | 61.00M | 49.00M | 52.00M | 57.00M | 37.00M | 33.00M |
| Other Income (Expense) | 279.00M | -346.00M | -48.00M | -157.00M | 1.01B | 276.00M | 133.00M | 11.00M | 437.00M | -26.00M |
| Pretax Income | 1.09B | -1.18B | -1.12B | -4.34B | 884.00M | 856.00M | 1.12B | 894.00M | 1.04B | 561.00M |
| Income Tax | 236.00M | 44.00M | 44.00M | 68.00M | 122.00M | 200.00M | 128.00M | 112.00M | 365.00M | 133.00M |
| Net Income | 850.00M | -1.22B | -1.16B | -4.40B | 762.00M | 656.00M | 1.00B | 826.00M | 726.00M | 463.00M |
| Net Income growth (YoY) | — | — | — | -677.95% | +16.16% | -34.53% | +21.31% | +13.77% | +56.80% | +0.22% |
| EPS (Basic) | 5.47 | -7.69 | -7.34 | -28.00 | 5.07 | 4.48 | 6.81 | 5.63 | 4.96 | 3.09 |
| EPS (Diluted) | 5.45 | -7.69 | -7.34 | -28.00 | 5.04 | 4.45 | 6.74 | 5.56 | 4.92 | 3.07 |
| Shares Outstanding (Basic) | 155.00M | 159.00M | 158.00M | 157.00M | 150.00M | 147.00M | 147.00M | 147.00M | 146.00M | 147.00M |
| Shares Outstanding (Diluted) | 156.00M | 159.00M | 158.00M | 157.00M | 151.00M | 148.00M | 149.00M | 149.00M | 148.00M | 148.00M |
| EBITDA | 1.08B | -479.00M | -637.00M | -3.79B | 128.00M | 767.00M | 1.17B | 1.06B | 762.00M | 728.00M |
| Gross Margin | 66.08% | 65.44% | 60.92% | 64.83% | 69.69% | 68.01% | 69.63% | 69.01% | 66.35% | 69.47% |
| Operating Margin | 18.58% | -19.05% | -23.73% | -91.16% | -2.72% | 17.91% | 27.80% | 26.49% | 22.02% | 24.48% |
| Net Margin | 19.57% | -27.97% | -25.78% | -96.07% | 16.84% | 20.25% | 28.28% | 24.78% | 26.38% | 19.31% |
This table shows 10 annual periods of Illumina's income statement, from FY 2025 back to FY 2016, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow ILMN's reporting calendar. What is a income statement?